Clene Inc. [CLNN] - Equity Issuance
Clene Inc. (CLNN) has filed to register common stock under the Securities Act, indicating its status as an emerging growth company.
Why this matters
Clene Inc., a pharmaceutical company incorporated in Delaware, specializes in developing innovative treatments within the pharmaceutical preparations industry. The company has filed to register common stock under the Securities Act, highlighting its status as an emerging growth company. This equity issuance was announced via a press release on September 15, 2026, and is part of a strategic move to raise capital. The offering is detailed in the company's Current Report on Form 8-K, which includes exhibits such as the opinion of Dorsey Whitney LLP and the form of the Securities Purchase Agreement.